{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:20:10Z","timestamp":1790630410087,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.1093\/ajcn\/82.3.611","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T02:01:28Z","timestamp":1518832888000},"page":"611-619","source":"Crossref","is-referenced-by-count":90,"title":["Systematic review of the effects of n\u22123 fatty acids in inflammatory bowel disease"],"prefix":"10.1016","volume":"82","author":[{"given":"Catherine H","family":"MacLean","sequence":"first","affiliation":[{"name":"From the Southern California Evidence-Based Practice Center, which includes RAND Health, Santa Monica, CA (CHM, WAM, SJN, RHG, WT, LGH, IMG, SR, PK, and SCM); the Greater Los Angeles VA Healthcare System Divisions of Rheumatology (CHM) and Gastroenterology (IMG), Los Angeles, CA; Clinical Decision Making and Healthcare, Toronto General Research Institute, Toronto General Hospital, Toronto, Ontari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter A","family":"Mojica","sequence":"additional","affiliation":[{"name":"From the Southern California Evidence-Based Practice Center, which includes RAND Health, Santa Monica, CA (CHM, WAM, SJN, RHG, WT, LGH, IMG, SR, PK, and SCM); the Greater Los Angeles VA Healthcare System Divisions of Rheumatology (CHM) and Gastroenterology (IMG), Los Angeles, CA; Clinical Decision Making and Healthcare, Toronto General Research Institute, Toronto General Hospital, Toronto, Ontari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydne J","family":"Newberry","sequence":"additional","affiliation":[{"name":"From the Southern California Evidence-Based Practice Center, which includes RAND Health, Santa Monica, CA (CHM, WAM, SJN, RHG, WT, LGH, IMG, SR, PK, and SCM); the Greater Los Angeles VA Healthcare System Divisions of Rheumatology (CHM) and Gastroenterology (IMG), Los Angeles, CA; Clinical Decision Making and Healthcare, Toronto General Research Institute, Toronto General Hospital, Toronto, Ontari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Pencharz","sequence":"additional","affiliation":[{"name":"From the Southern California Evidence-Based Practice Center, which includes RAND Health, Santa Monica, CA (CHM, WAM, SJN, RHG, WT, LGH, IMG, SR, PK, and SCM); the Greater Los Angeles VA Healthcare System Divisions of Rheumatology (CHM) and Gastroenterology (IMG), Los Angeles, CA; Clinical Decision Making and Healthcare, Toronto General Research Institute, Toronto General Hospital, Toronto, Ontari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena Hasenfeld","family":"Garland","sequence":"additional","affiliation":[{"name":"From the Southern California Evidence-Based Practice Center, which includes RAND Health, Santa Monica, CA (CHM, WAM, SJN, RHG, WT, LGH, IMG, SR, PK, and SCM); the Greater Los Angeles VA Healthcare System Divisions of Rheumatology (CHM) and Gastroenterology (IMG), Los Angeles, CA; Clinical Decision Making and Healthcare, Toronto General Research Institute, Toronto General Hospital, Toronto, Ontari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Tu","sequence":"additional","affiliation":[{"name":"From the Southern California Evidence-Based Practice Center, which includes RAND Health, Santa Monica, CA (CHM, WAM, SJN, RHG, WT, LGH, IMG, SR, PK, and SCM); the Greater Los Angeles VA Healthcare System Divisions of Rheumatology (CHM) and Gastroenterology (IMG), Los Angeles, CA; Clinical Decision Making and Healthcare, Toronto General Research Institute, Toronto General Hospital, Toronto, Ontari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara G","family":"Hilton","sequence":"additional","affiliation":[{"name":"From the Southern California Evidence-Based Practice Center, which includes RAND Health, Santa Monica, CA (CHM, WAM, SJN, RHG, WT, LGH, IMG, SR, PK, and SCM); the Greater Los Angeles VA Healthcare System Divisions of Rheumatology (CHM) and Gastroenterology (IMG), Los Angeles, CA; Clinical Decision Making and Healthcare, Toronto General Research Institute, Toronto General Hospital, Toronto, Ontari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M","family":"Gralnek","sequence":"additional","affiliation":[{"name":"From the Southern California Evidence-Based Practice Center, which includes RAND Health, Santa Monica, CA (CHM, WAM, SJN, RHG, WT, LGH, IMG, SR, PK, and SCM); the Greater Los Angeles VA Healthcare System Divisions of Rheumatology (CHM) and Gastroenterology (IMG), Los Angeles, CA; Clinical Decision Making and Healthcare, Toronto General Research Institute, Toronto General Hospital, Toronto, Ontari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Rhodes","sequence":"additional","affiliation":[{"name":"From the Southern California Evidence-Based Practice Center, which includes RAND Health, Santa Monica, CA (CHM, WAM, SJN, RHG, WT, LGH, IMG, SR, PK, and SCM); the Greater Los Angeles VA Healthcare System Divisions of Rheumatology (CHM) and Gastroenterology (IMG), Los Angeles, CA; Clinical Decision Making and Healthcare, Toronto General Research Institute, Toronto General Hospital, Toronto, Ontari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja","family":"Khanna","sequence":"additional","affiliation":[{"name":"From the Southern California Evidence-Based Practice Center, which includes RAND Health, Santa Monica, CA (CHM, WAM, SJN, RHG, WT, LGH, IMG, SR, PK, and SCM); the Greater Los Angeles VA Healthcare System Divisions of Rheumatology (CHM) and Gastroenterology (IMG), Los Angeles, CA; Clinical Decision Making and Healthcare, Toronto General Research Institute, Toronto General Hospital, Toronto, Ontari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally C","family":"Morton","sequence":"additional","affiliation":[{"name":"From the Southern California Evidence-Based Practice Center, which includes RAND Health, Santa Monica, CA (CHM, WAM, SJN, RHG, WT, LGH, IMG, SR, PK, and SCM); the Greater Los Angeles VA Healthcare System Divisions of Rheumatology (CHM) and Gastroenterology (IMG), Los Angeles, CA; Clinical Decision Making and Healthcare, Toronto General Research Institute, Toronto General Hospital, Toronto, Ontari"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"key\n\t\t\t\t20180216210106_R1","first-page":"111","article-title":"Lipids: cellular metabolism","volume-title":"Chapter 10. Present knowledge in nutrition","author":"Jones","year":"2001"},{"key":"key\n\t\t\t\t20180216210106_R2","doi-asserted-by":"crossref","first-page":"343S","DOI":"10.1093\/ajcn\/71.1.343s","article-title":"Dietary polyunsaturated fatty acids and inflammatory mediator production","volume":"71","author":"James","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"key\n\t\t\t\t20180216210106_R3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0753-3322(02)00253-6","article-title":"The importance of the ratio of omega-6\/omega-3 essential fatty acids","volume":"56","author":"Simopoulos","year":"2002","journal-title":"Biomed Pharmacother"},{"key":"key\n\t\t\t\t20180216210106_R4","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180216210106_R5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0025-7125(16)30581-8","article-title":"Epidemiology of inflam bowel diseases","volume":"74","author":"Whelan","year":"1990","journal-title":"Med Clin North Am"},{"key":"key\n\t\t\t\t20180216210106_R6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0753-3322(01)80006-8","article-title":"Psychosocial aspects of inflammatory bowel disease","volume":"54","author":"Casati","year":"2000","journal-title":"Biomed Pharmacother"},{"key":"key\n\t\t\t\t20180216210106_R7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0889-8553(05)70056-X","article-title":"Epidemiology and the natural course of inflammatory bowel disease","volume":"28","author":"Andres","year":"1999","journal-title":"Gastroenterol Clin North Am"},{"key":"key\n\t\t\t\t20180216210106_R8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.0954-6820.1980.tb01221.x","article-title":"Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950\u20131974","volume":"208","author":"Kromann","year":"1980","journal-title":"Acta Med Scand"},{"key":"key\n\t\t\t\t20180216210106_R9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/ajcn\/63.5.741","article-title":"Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n\u22126 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan","volume":"63","author":"Shoda","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"key\n\t\t\t\t20180216210106_R10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1023\/A:1018873217192","article-title":"Serum n\u22123 polyunsaturated fatty acids are depleted in Crohn\u2019s disease","volume":"42","author":"Kuroki","year":"1997","journal-title":"Dig Dis Sci"},{"key":"key\n\t\t\t\t20180216210106_R11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/07315724.1986.10720125","article-title":"Control of polyunsaturated fatty acids in tissue lipids","volume":"5","author":"Holman","year":"1986","journal-title":"J Am Col Nutr"},{"key":"key\n\t\t\t\t20180216210106_R12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0026-0495(96)90194-8","article-title":"Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders","volume":"45","author":"Siguel","year":"1996","journal-title":"Metab Clin Exp"},{"key":"key\n\t\t\t\t20180216210106_R13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0955-2863(00)00141-8","article-title":"Review: the role of omega 3 fatty acids in intestinal inflammation","volume":"12","author":"Teitelbaum","year":"2001","journal-title":"J Nutr Biochem"},{"key":"key\n\t\t\t\t20180216210106_R14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180216210106_R15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180216210106_R16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"key\n\t\t\t\t20180216210106_R17","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/gut.33.7.922","article-title":"Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial","volume":"33","author":"Hawthorne","year":"1992","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180216210106_R18","first-page":"98","article-title":"Fish oil in ulcerative colitis: final results of a controlled clinical trial","volume":"A174","author":"Hawthorne","year":"1990","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180216210106_R19","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1572-0241.1998.229_a.x","article-title":"Distal procto-colitis, natural cytotoxicity, and essential fatty acids","volume":"93","author":"Almallah","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180216210106_R20","first-page":"432","article-title":"Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study","volume":"87","author":"Aslan","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180216210106_R21","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM199606133342401","article-title":"Effect of an enteric-coated fish-oil preparation on relapses in Crohn\u2019s disease","volume":"334","author":"Belluzzi","year":"1996","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180216210106_R22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2036.1993.tb00085.x","article-title":"A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis","volume":"7","author":"Greenfield","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180216210106_R23","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/BF02093614","article-title":"N-3 fatty acids only delay early relapse of ulcerative colitis in remission","volume":"41","author":"Loeschke","year":"1996","journal-title":"Dig Dis Sci"},{"key":"key\n\t\t\t\t20180216210106_R24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2796.1989.tb01461.x","article-title":"Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease\u2013a randomized, placebo-controlled, double-blind cross-over trial","volume":"225","author":"Lorenz","year":"1989","journal-title":"J Intern Med Suppl"},{"key":"key\n\t\t\t\t20180216210106_R25","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3109\/00365529609010352","article-title":"Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn\u2019s disease. A randomized controlled multicenter trial. Study Group Members (German Crohn\u2019s Disease Study Group)","volume":"31","author":"Lorenz-Meyer","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"key\n\t\t\t\t20180216210106_R26","first-page":"138","article-title":"A prospective, randomized, placebo-controlled study of fish oil in ulcerative colitis","volume":"9","author":"Mantzaris","year":"1996","journal-title":"Hellen J Gastroenterol"},{"key":"key\n\t\t\t\t20180216210106_R27","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1046\/j.1365-2036.2002.01286.x","article-title":"A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis","volume":"16","author":"Middleton","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180216210106_R28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.7326\/0003-4819-116-8-609","article-title":"Dietary supplementation with fish oil in ulcerative colitis","volume":"116","author":"Stenson","year":"1992","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180216210106_R29","first-page":"73","article-title":"Clinical response of ulcerative colitis with dietary omega-3 fatty acids: a double-blind randomized study","volume":"87","author":"Varghese","year":"2000","journal-title":"Br J Surg"},{"key":"key\n\t\t\t\t20180216210106_R30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gut.27.1.92","article-title":"Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease","volume":"27","author":"Gomes","year":"1986","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180216210106_R31","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/0016-5085(87)90621-4","article-title":"5-Amniosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis","volume":"92","author":"Sutherland","year":"1987","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180216210106_R32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180216210106_R33","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1001\/jama.291.20.2457","article-title":"Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles","volume":"291","author":"Chan","year":"2004","journal-title":"JAMA"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcn\/article-pdf\/82\/3\/611\/23959969\/znu00905000611.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T10:24:17Z","timestamp":1672827857000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcn\/article\/82\/3\/611\/4862993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,1]]},"references-count":33,"aliases":["10.1093\/ajcn.82.3.611","10.1093\/ajcn.82.3.611"],"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcn\/82.3.611","relation":{},"ISSN":["0002-9165","1938-3207"],"issn-type":[{"value":"0002-9165","type":"print"},{"value":"1938-3207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,9]]},"published":{"date-parts":[[2005,9,1]]}}}